106 related articles for article (PubMed ID: 17266643)
21. Small stress molecules inhibit aggregation and neurotoxicity of prion peptide 106-126.
Kanapathipillai M; Ku SH; Girigoswami K; Park CB
Biochem Biophys Res Commun; 2008 Jan; 365(4):808-13. PubMed ID: 18039468
[TBL] [Abstract][Full Text] [Related]
22. Prion protein expression in muscle cells and toxicity of a prion protein fragment.
Brown DR; Schmidt B; Groschup MH; Kretzschmar HA
Eur J Cell Biol; 1998 Jan; 75(1):29-37. PubMed ID: 9523152
[TBL] [Abstract][Full Text] [Related]
23. Intracellular mechanisms mediating the neuronal death and astrogliosis induced by the prion protein fragment 106-126.
Thellung S; Florio T; Corsaro A; Arena S; Merlino M; Salmona M; Tagliavini F; Bugiani O; Forloni G; Schettini G
Int J Dev Neurosci; 2000; 18(4-5):481-92. PubMed ID: 10817932
[TBL] [Abstract][Full Text] [Related]
24. The hydrophobic core sequence modulates the neurotoxic and secondary structure properties of the prion peptide 106-126.
Jobling MF; Stewart LR; White AR; McLean C; Friedhuber A; Maher F; Beyreuther K; Masters CL; Barrow CJ; Collins SJ; Cappai R
J Neurochem; 1999 Oct; 73(4):1557-65. PubMed ID: 10501201
[TBL] [Abstract][Full Text] [Related]
25. Immunomodulation of the human prion peptide 106-126 aggregation.
Hanan E; Goren O; Eshkenazy M; Solomon B
Biochem Biophys Res Commun; 2001 Jan; 280(1):115-20. PubMed ID: 11162487
[TBL] [Abstract][Full Text] [Related]
26. High hydrophobic amino acid exposure is responsible of the neurotoxic effects induced by E200K or D202N disease-related mutations of the human prion protein.
Corsaro A; Thellung S; Bucciarelli T; Scotti L; Chiovitti K; Villa V; D'Arrigo C; Aceto A; Florio T
Int J Biochem Cell Biol; 2011 Mar; 43(3):372-82. PubMed ID: 21094273
[TBL] [Abstract][Full Text] [Related]
27. p75(NTR) activation of NF-kappaB is involved in PrP106-126-induced apoptosis in mouse neuroblastoma cells.
Bai Y; Li Q; Yang J; Zhou X; Yin X; Zhao D
Neurosci Res; 2008 Sep; 62(1):9-14. PubMed ID: 18602709
[TBL] [Abstract][Full Text] [Related]
28. FTY720 protects neuronal cells from damage induced by human prion protein by inactivating the JNK pathway.
Moon MH; Jeong JK; Lee YJ; Park SY
Int J Mol Med; 2013 Dec; 32(6):1387-93. PubMed ID: 24142108
[TBL] [Abstract][Full Text] [Related]
29. Morphology and secondary structure of stable beta-oligomers formed by amyloid peptide PrP(106-126).
Walsh P; Yau J; Simonetti K; Sharpe S
Biochemistry; 2009 Jun; 48(25):5779-81. PubMed ID: 19476383
[TBL] [Abstract][Full Text] [Related]
30. Amino-terminally truncated prion protein PrP90-231 induces microglial activation in vitro.
Thellung S; Corsaro A; Villa V; Venezia V; Nizzari M; Bisaglia M; Russo C; Schettini G; Aceto A; Florio T
Ann N Y Acad Sci; 2007 Jan; 1096():258-70. PubMed ID: 17405937
[TBL] [Abstract][Full Text] [Related]
31. In vivo and in vitro neurotoxicity of the human prion protein (PrP) fragment P118-135 independently of PrP expression.
Chabry J; Ratsimanohatra C; Sponne I; Elena PP; Vincent JP; Pillot T
J Neurosci; 2003 Jan; 23(2):462-9. PubMed ID: 12533606
[TBL] [Abstract][Full Text] [Related]
32. Species-specific anti-apoptotic activity of cellular prion protein in a mouse PrP-deficient neuronal cell line transfected with mouse, hamster, and bovine Prnp.
Wu G; Nakajima K; Takeyama N; Yukawa M; Taniuchi Y; Sakudo A; Onodera T
Neurosci Lett; 2008 Nov; 446(1):11-5. PubMed ID: 18809465
[TBL] [Abstract][Full Text] [Related]
33. Impairment of superoxide dismutase activation by N-terminally truncated prion protein (PrP) in PrP-deficient neuronal cell line.
Sakudo A; Lee DC; Saeki K; Nakamura Y; Inoue K; Matsumoto Y; Itohara S; Onodera T
Biochem Biophys Res Commun; 2003 Aug; 308(3):660-7. PubMed ID: 12914801
[TBL] [Abstract][Full Text] [Related]
34. The copper(II) adduct of the unstructured region of the amyloidogenic fragment derived from the human prion protein is redox-active at physiological pH.
Shearer J; Soh P
Inorg Chem; 2007 Feb; 46(3):710-9. PubMed ID: 17257012
[TBL] [Abstract][Full Text] [Related]
35. Contribution of two conserved glycine residues to fibrillogenesis of the 106-126 prion protein fragment. Evidence that a soluble variant of the 106-126 peptide is neurotoxic.
Florio T; Paludi D; Villa V; Principe DR; Corsaro A; Millo E; Damonte G; D'Arrigo C; Russo C; Schettini G; Aceto A
J Neurochem; 2003 Apr; 85(1):62-72. PubMed ID: 12641727
[TBL] [Abstract][Full Text] [Related]
36. Aspirin inhibits cytotoxicity of prion peptide PrP106-126 to neuronal cells associated with microglia activation in vitro.
Yang L; Zhou X; Yang J; Yin X; Han L; Zhao D
J Neuroimmunol; 2008 Aug; 199(1-2):10-7. PubMed ID: 18547651
[TBL] [Abstract][Full Text] [Related]
37. Anterograde axonal transport of chicken cellular prion protein (PrPc) in vivo requires its N-terminal part.
Butowt R; Davies P; Brown DR
J Neurosci Res; 2007 Sep; 85(12):2567-79. PubMed ID: 17335074
[TBL] [Abstract][Full Text] [Related]
38. Fibrillar prion peptide PrP(106-126) treatment induces Dab1 phosphorylation and impairs APP processing and Abeta production in cortical neurons.
Gavín R; Ureña J; Rangel A; Pastrana MA; Requena JR; Soriano E; Aguzzi A; Del Río JA
Neurobiol Dis; 2008 May; 30(2):243-54. PubMed ID: 18374587
[TBL] [Abstract][Full Text] [Related]
39. PrP N-terminal domain triggers PrP(Sc)-like aggregation of Dpl.
Erlich P; Cesbron JY; Lemaire-Vieille C; Curt A; Andrieu JP; Schoehn G; Jamin M; Gagnon J
Biochem Biophys Res Commun; 2008 Jan; 365(3):478-83. PubMed ID: 17997980
[TBL] [Abstract][Full Text] [Related]
40. Apoptosis-mediated neurotoxicity induced by beta-amyloid and PrP fragments.
Forloni G; Bugiani O; Tagliavini F; Salmona M
Mol Chem Neuropathol; 1996; 28(1-3):163-71. PubMed ID: 8871955
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
